ViiV Advances Ultra Long-Acting HIV Care at CROI

ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026

LONDON--(BUSINESS WIRE)--Feb 17, 2026-

CROI 2026: Resources and what to watch

The annual Conference on Retroviruses and Opportunistic Infections (CROI), taking place February 22–25, 2026, in Denver, Colorado, will once again kick off the year as the premier scientific convening for our field.    AVAC will be tracking the HIV and STI science at CROI 2026, including advances in long-acting HIV prevention, evolving science around cure, and important discussions on the impact of the global funding crisis on research, developm…

ViiV Advances Ultra Long-Acting HIV Care at CROI

ViiV Healthcare presents ultra-long-acting HIV pipeline data, including third-generation INSTI research, at CROI 2026.